{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:11:38Z","timestamp":1761919898061},"reference-count":62,"publisher":"FapUNIFESP (SciELO)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[2014,11]]},"abstract":"<jats:p>Potential environmental modifiable factors involved in multiple sclerosis (MS) include low adherence to treatment, smoking, obesity, low levels of liposoluble vitamins A and D, high consumption of salt, and a sedentary lifestyle. Chronic tobacco use, obesity, sedentarism and insufficient levels of these vitamins all contribute to maintenance of a proinflammatory state. It is unlikely that there will be noticeable improvement in the inflammatory condition of MS if stopping smoking, reducing weight, exercising, increasing vitamin levels are done in an isolated and erratic manner. Modification of each and every one of these environmental risk factors is likely to be an important approach in the management of MS. The present review presents the arguments for an association between these hazardous modifiable factors and the chronic inflammatory state observed in MS.<\/jats:p>","DOI":"10.1590\/0004-282x20140159","type":"journal-article","created":{"date-parts":[[2014,11,15]],"date-time":"2014-11-15T18:05:16Z","timestamp":1416074716000},"page":"889-894","source":"Crossref","is-referenced-by-count":19,"title":["Modifiable environmental factors in multiple sclerosis"],"prefix":"10.1590","volume":"72","author":[{"given":"Yara Dadalti","family":"Fragoso","sequence":"first","affiliation":[{"name":"Universidade Metropolitana de Santos, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"issue":"13","key":"ref1","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple sclerosis","volume":"343","author":"Noseworthy JH","year":"2000","journal-title":"N Engl J Med"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1586\/14737175.2014.874947","article-title":"We know how to prescribe natalizumab for multiple sclerosis, but do we know how to withdraw it?","volume":"14","author":"Fragoso YD","year":"2014","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s13311-012-0163-4","article-title":"Interferon beta and glatiramer acetate therapy","volume":"10","author":"McGraw CA","year":"2013","journal-title":"Neurotherapeutics"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S0022-510X(09)70012-7","article-title":"Concepts of induction and escalation therapy in multiple sclerosis","volume":"277","author":"Rieckmann P","year":"2009","journal-title":"J Neurol Sci"},{"issue":"11","key":"ref5","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/0961203306069344","article-title":"Cigarette smoking and autoimmune disease: what can we learn from epidemiology?","volume":"15","author":"Costenbader KH","year":"2006","journal-title":"Lupus"},{"issue":"3-4","key":"ref6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000332765","article-title":"Cigarette smoking and the risk of multiple sclerosis: a sibling case-control study in Isfahan, Iran","volume":"37","author":"Maghzi AH","year":"2011","journal-title":"Neuroepidemiology"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1046\/j.1365-2362.2001.00842.x","article-title":"Effects of smoking on activation markers, Fas expression and apoptosis of peripheral blood lymphocytes","volume":"31","author":"Bijl M","year":"2001","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","DOI":"10.1186\/1476-9255-7-30","article-title":"Fas (CD95) induces rapid, TLR4\/IRAK4-dependent release of pro-inflammatory HMGB1 from macrophages","volume":"7","author":"Wang F","year":"2010","journal-title":"J Inflamm (Lond)"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01902140490252858","article-title":"Effects of cigarette smoke exposure and cessation on inflammatory cells and matrix metalloproteinase activity in mice","volume":"30","author":"Seagrave J","year":"2004","journal-title":"Exp Lung Res"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0378-4274(00)00270-8","article-title":"Immunological findings in cigarette smokers","volume":"118","author":"Moszczy\u0144ski P","year":"2001","journal-title":"Toxicol Lett"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1165\/rcmb.2003-0259OC","article-title":"Cigarette smoke decreases pulmonary dendritic cells and impacts antiviral immune responsiveness","volume":"30","author":"Robbins CS","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"Pt 7","key":"ref12","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1093\/brain\/awt139","article-title":"Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study","volume":"136","author":"Manouchehrinia A","year":"2013","journal-title":"Brain"},{"issue":"1-2","key":"ref13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2013.04.003","article-title":"Smoking as a risk factor for development of secondary progressive multiple sclerosis: A study in IRAN, Guilan","volume":"330","author":"Roudbari SA","year":"2013","journal-title":"J Neurol Sci"},{"issue":"8","key":"ref14","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1177\/1352458513515086","article-title":"Smokers run increased risk of developing anti-natalizumab antibodies","volume":"20","author":"Hedstr\u00f6m A","year":"2013","journal-title":"Mult Scler"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s00415-014-7397-5","article-title":"Smoking and multiple sclerosis: evidence for latitudinal and temporal variation","volume":"261","author":"O'Gorman C","year":"2014","journal-title":"J Neurol"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/EDE.0000000000000089","article-title":"Smoking and risk of multiple sclerosis: evidence of modification by NAT1 variants","volume":"25","author":"Briggs FB","year":"2014","journal-title":"Epidemiology"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1177\/1352458511399610","article-title":"Exposure to environmental tobacco smoke is associated with increased risk for multiple sclerosis","volume":"17","author":"Hedstr\u00f6m AK","year":"2011","journal-title":"Mult Scler"},{"issue":"19","key":"ref18","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1212\/WNL.0b013e3181c0d6e0","article-title":"Body size and risk of MS in two cohorts of US women","volume":"73","author":"Munger KL","year":"2009","journal-title":"Neurology"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1177\/1352458513483889","article-title":"Childhood body mass index and multiple sclerosis risk: a long-term cohort study","volume":"19","author":"Munger K","year":"2013","journal-title":"Mult Scler"},{"issue":"9","key":"ref20","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1177\/1352458512436596","article-title":"High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women","volume":"18","author":"Hedstr\u00f6m AK","year":"2012","journal-title":"Mult Scler"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/ije\/dyu045","article-title":"Body mass index and risk of autoimmune diseases: a study within the Danish National Birth Cohort","volume":"43","author":"Harps\u00f8e MC","year":"2014","journal-title":"Int J Epidemiol"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","DOI":"10.1007\/s11882-013-0404-6","article-title":"Role of \"western diet\" in inflammatory autoimmune diseases","volume":"14","author":"Manzel A","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1-2","key":"ref23","first-page":"103","article-title":"Focus on adipokines","volume":"106","author":"Fietta P","year":"2013","journal-title":"Theor Biol Forum"},{"issue":"1-2","key":"ref24","first-page":"19","article-title":"Adipocytokines and obesity -linked disorders","volume":"74","author":"Ouchi N","year":"2012","journal-title":"Nagoya J Med Sci"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi S","year":"2008","journal-title":"Cell"},{"issue":"11","key":"ref26","doi-asserted-by":"crossref","DOI":"10.4161\/onci.26586","article-title":"The interplay between regulatory T cells and metabolism in immune regulation","volume":"2","author":"Zeng H","year":"2013","journal-title":"Oncoimmunology"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2007.01.011","article-title":"A key role of leptin in the control of regulatory T cell proliferation","volume":"26","author":"Rosa V","year":"2007","journal-title":"Immunity"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/oby.20087","article-title":"Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk","volume":"21","author":"Wagner NM","year":"2013","journal-title":"Obesity (Silver Spring)"},{"issue":"11","key":"ref29","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1002\/art.34637","article-title":"Leptin exacerbates collagen-induced arthritis via enhancement of Th17 cell response","volume":"64","author":"Deng J","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"7","key":"ref30","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.4049\/jimmunol.1203275","article-title":"Cutting edge: Leptin-induced ROR\u03b3t expression in CD4+ T cells promotes Th17 responses in systemic lupus erythematosus","volume":"190","author":"Yu Y","year":"2013","journal-title":"J Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000353557","article-title":"Regulatory T cells, leptin and angiogenesis","volume":"99","author":"Pucino V","year":"2014","journal-title":"Chem Immunol Allergy"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s40263-014-0148-4","article-title":"The evidence for a beneficial role of vitamin A in multiple sclerosis","volume":"28","author":"Fragoso YD","year":"2014","journal-title":"CNS Drugs"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2011.07.002","article-title":"The role of retinoic acid in tolerance and immunity","volume":"35","author":"Hall JA","year":"2011","journal-title":"Immunity"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nn.2702","article-title":"Retinoid X receptor gamma signaling accelerates CNS remyelination","volume":"14","author":"Huang JK","year":"2011","journal-title":"Nat Neurosci"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1172\/JCI115438","article-title":"Immunosuppressive activity of 13-cis-retinoic acid and prevention of experimental autoimmune encephalomyelitis in rats","volume":"88","author":"Massacesi L","year":"1991","journal-title":"J Clin Invest"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4049\/jimmunol.154.1.450","article-title":"Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course","volume":"154","author":"Racke MK","year":"1995","journal-title":"J Immunol"},{"issue":"1-2","key":"ref37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jneuroim.2007.11.014","article-title":"Vitamin D as an immune modulator in multiple sclerosis, a review","volume":"194","author":"Smolders J","year":"2008","journal-title":"J Neuroimmunol"},{"issue":"9","key":"ref38","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.4049\/jimmunol.167.9.4974","article-title":"1\u03b1, 25-dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells","volume":"167","author":"Boonstra A","year":"2001","journal-title":"J. Immunol"},{"issue":"12","key":"ref39","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.imbio.2012.07.018","article-title":"1,25-Dihydroxyvitamin D3 curtails the inflammatory and T cell stimulatory capacity of macrophages through an IL-10-dependent mechanism","volume":"217","author":"Korf H","year":"2012","journal-title":"Immunobiology"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jamaneurol.2013.5993","article-title":"Vitamin D as an early predictor of multiple sclerosis activity and progression","volume":"71","author":"Ascherio A","year":"2014","journal-title":"JAMA Neurol"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/jnnp-2011-301876","article-title":"A randomised, double blind, placebo controlled trial with vitamin D3 as an add-on treatment to interferon \u03b2-1b in patients with multiple sclerosis","volume":"83","author":"Soilu-H\u00e4nninen M","year":"2012","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.autrev.2012.07.007","article-title":"Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature","volume":"12","author":"Antico A","year":"2012","journal-title":"Autoimmun Rev"},{"key":"ref43","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g2035","article-title":"Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials","volume":"348","author":"Theodoratou E","year":"2014","journal-title":"BMJ"},{"issue":"3","key":"ref44","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/WCO.0b013e3283533a7e","article-title":"Vitamin D and multiple sclerosis: epidemiology, immunology, and genetics","volume":"25","author":"Simon KC","year":"2012","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.imlet.2010.07.002","article-title":"1alpha,25-Dihydroxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cells","volume":"134","author":"Ikeda U","year":"2010","journal-title":"Immunol Lett"},{"issue":"9","key":"ref46","first-page":"1651","article-title":"Exercise therapy and multiple sclerosis : a systematic review","volume":"261","author":"S\u00e1 MJ","year":"2013","journal-title":"J Neurol"},{"issue":"11","key":"ref47","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.intimp.2010.08.008","article-title":"Combined exercise training reduces IFN-\u03b3 and IL-17 levels in the plasma and the supernatant of peripheral blood mononuclear cells in women with multiple sclerosis","volume":"10","author":"Golzari Z","year":"2010","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"ref48","doi-asserted-by":"crossref","first-page":"138","DOI":"10.7224\/1537-2073.2012-037","article-title":"Aerobic exercise in people with multiple sclerosis: its feasibility and secondary benefits","volume":"15","author":"Swank C","year":"2013","journal-title":"Int J MS Care"},{"issue":"2","key":"ref49","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11845-010-0633-9","article-title":"Effects of exercise and physical activity on depression","volume":"180","author":"Dinas PC","year":"2011","journal-title":"Ir J Med Sci"},{"issue":"7446","key":"ref50","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature11868","article-title":"Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells","volume":"496","author":"Kleinewietfeld M","year":"2013","journal-title":"Nature"},{"issue":"7446","key":"ref51","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nature11984","article-title":"Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1","volume":"496","author":"Wu C","year":"2013","journal-title":"Nature"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2119\/molmed.2011.00311","article-title":"Influence of dietary components on regulatory T cells","volume":"18","author":"Issazadeh-Navikas S","year":"2012","journal-title":"Mol Med"},{"issue":"11","key":"ref53","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.3390\/nu5114305","article-title":"Advances in nutritional research on regulatory T-cells","volume":"5","author":"Kim W","year":"2013","journal-title":"Nutrients"},{"issue":"3","key":"ref54","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/jamaneurol.2013.5858","article-title":"Alcohol as a modifiable lifestyle factor affecting multiple sclerosis risk","volume":"71","author":"Hedstr\u00f6m AK","year":"2014","journal-title":"JAMA Neurol"},{"issue":"1-2","key":"ref55","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jns.2013.12.029","article-title":"Alcohol and substance use in multiple sclerosis","volume":"338","author":"Beier M","year":"2014","journal-title":"J Neurol Sci"},{"issue":"1","key":"ref56","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.imlet.2010.12.009","article-title":"Ethanol extract from birch bark (Betula pubescens) suppresses human dendritic cell mediated Th1 responses and directs it towards a Th17 regulatory response in vitro","volume":"136","author":"Freysdottir J","year":"2011","journal-title":"Immunol Lett"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2147\/NDT.S17522","article-title":"When neurologist and patient disagree on reasonable risk: new challenges in prescribing for patients with multiple sclerosis","volume":"7","author":"Kachuck NJ","year":"2011","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"12","key":"ref58","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1177\/1352458510379819","article-title":"Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists","volume":"16","author":"Heesen C","year":"2010","journal-title":"Mult Scler"},{"issue":"5","key":"ref59","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/jcbfm.2013.31","article-title":"What went wrong? The flawed concept of cerebrospinal venous insufficiency","volume":"33","author":"Valdueza JM","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"ref60","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000096853","article-title":"Lifestyle factors and multiple sclerosis: a case-control study in Belgrade","volume":"27","author":"Pekmezovic T","year":"2006","journal-title":"Neuroepidemiology"},{"issue":"1","key":"ref61","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1586\/14737175.2014.864952","article-title":"Vitamin D and multiple sclerosis: where do we go from here?","volume":"14","author":"Salzer J","year":"2014","journal-title":"Expert Rev Neurother"},{"issue":"1-2","key":"ref62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2011.03.026","article-title":"Biomarkers of disease activity in multiple sclerosis","volume":"305","author":"Graber JJ","year":"2011","journal-title":"J Neurol Sci"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v72n11\/0004-282X-anp-72-11-889.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T06:04:12Z","timestamp":1689660252000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2014001100889&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":62,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0004-282X2014001100889"],"URL":"https:\/\/doi.org\/10.1590\/0004-282x20140159","relation":{},"ISSN":["0004-282X"],"issn-type":[{"value":"0004-282X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}